Hostname: page-component-cd9895bd7-q99xh Total loading time: 0 Render date: 2024-12-27T10:47:23.255Z Has data issue: false hasContentIssue false
  • English
  • Français

Clozapine and NMS

Published online by Cambridge University Press:  02 January 2018

Peter F. Buckley  and
Herbert Y. Meltzer
Peter F. Buckley
Affiliation:
Department of Psychiatry Case Western Reserve University 2040 Abington Road Cleveland, Ohio 44106, USA
Herbert Y. Meltzer
Affiliation:
Department of Psychiatry Case Western Reserve University 2040 Abington Road Cleveland, Ohio 44106, USA
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Columns
Information
The British Journal of Psychiatry , Volume 162 , Issue 4 , April 1993 , pp. 566
Copyright
Copyright © Royal College of Psychiatrists, 1993 

References

Buckley, P., Freyne, A., McCarthy, A., et al (1991) Neuroleptic malignant syndrome – a follow-up study. Irish Journal of Medical Science, 160, 45–47.Google Scholar
Meltzer, H. Y. (1973) Rigidity, hyperpyrexia and coma following fluphenazine enthanate. Psychopharmacologia, 29, 337–346.CrossRefGoogle Scholar
Meltzer, H. Y. (1992) Dimensions of outcome with clozapine. British Journal of Psychiatry, 160 (suppl. 17), 22–29.CrossRefGoogle Scholar
Pope, H. G. Jr, Aizley, H. G., Keck, P. E. Jr, et al (1991) Neuroleptic malignant syndrome: long–term follow-up of 20 cases. Journal of Clinical Psychiatry, 52, 208–212.Google Scholar
Rosebush, P. I., Stewart, T. D. & Gelenberg, A. J. (1989) Twenty neuroleptic rechallenges after neuroleptic malignant syndrome in 15 patients. Journal of Clinical Psychiatry, 50, 295–298.Google ScholarPubMed
Submit a response

eLetters

No eLetters have been published for this article.